1. Home
  2. News
  3. Recce Pharmaceuticals Ltd.
  4. Hong Kong Patent Granted for RECCE Anti-Infectives
More Recce Pharmaceuticals Ltd. news
Recce Pharmaceuticals Ltd.ASX: RCE

Hong Kong Patent Granted for RECCE Anti-Infectives

Nov 26, 2025 at 11:26 PM EST · Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · Nov 26, 2025 at 11:26 PM EST · 3 pages · English

On 6ix: 6ix.com/news/hong-kong-patent-granted-for-recce-anti-infectives

Recce Pharmaceuticals Ltd. on 6ix

Story so far

  • China Patent Accepted for RECCE Anti-InfectivesMay 26, 2025
  • Recce Pharmaceuticals Granted Japanese Patent for RECCE® Anti-InfectivesFeb 27, 2025
  • Japan Patent Allowance for RECCE Anti-InfectivesFeb 26, 2025

Earlier from Recce Pharmaceuticals

  • Positive Efficacy Data for Inhaled R327 in HAP/VAP ModelNov 25, 2025
  • Patient Dosing Underway in Ph 3 Indonesia DFI TrialSep 25, 2025
  • Preliminary Final ReportAug 29, 2025
  • R327G Highly Effective in Burn Wounds ModelAug 12, 2025
  • Recce Signs Debt Facility with Avenue Capital GroupJun 17, 2025

Later from Recce Pharmaceuticals

  • RCE Awarded Advanced Overseas Finding up to A$85mDec 15, 2025
  • AUD $5.3m R&D Rebate ReceivedJan 13
  • Quarterly Activities/Appendix 4C Cash Flow ReportJan 30
  • Recce Enters Second U.S. Department of Defense R&D AgreementFeb 1
  • Appendix 4D and Interim Financial ReportFeb 27
All Recce Pharmaceuticals news releases↗

Follow Recce Pharmaceuticals into a list and get an email when it puts out news.

Follow Recce Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer